296 related articles for article (PubMed ID: 24832700)
1. Emerging cystic fibrosis pathogens and the microbiome.
Mahenthiralingam E
Paediatr Respir Rev; 2014 Jun; 15 Suppl 1():13-5. PubMed ID: 24832700
[TBL] [Abstract][Full Text] [Related]
2. The microbiome and emerging pathogens in cystic fibrosis and non-cystic fibrosis bronchiectasis.
Green H; Jones AM
Semin Respir Crit Care Med; 2015 Apr; 36(2):225-35. PubMed ID: 25826590
[TBL] [Abstract][Full Text] [Related]
3. The cystic fibrosis lung microbiome.
Surette MG
Ann Am Thorac Soc; 2014 Jan; 11 Suppl 1():S61-5. PubMed ID: 24437409
[TBL] [Abstract][Full Text] [Related]
4. Rapid Detection of Emerging Pathogens and Loss of Microbial Diversity Associated with Severe Lung Disease in Cystic Fibrosis.
Flight WG; Smith A; Paisey C; Marchesi JR; Bull MJ; Norville PJ; Mutton KJ; Webb AK; Bright-Thomas RJ; Jones AM; Mahenthiralingam E
J Clin Microbiol; 2015 Jul; 53(7):2022-9. PubMed ID: 25878338
[TBL] [Abstract][Full Text] [Related]
5. Denitrification by cystic fibrosis pathogens - Stenotrophomonas maltophilia is dormant in sputum.
Kolpen M; Kragh KN; Bjarnsholt T; Line L; Hansen CR; Dalbøge CS; Hansen N; Kühl M; Høiby N; Jensen PØ
Int J Med Microbiol; 2015 Jan; 305(1):1-10. PubMed ID: 25441256
[TBL] [Abstract][Full Text] [Related]
6. Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis.
Parkins MD; Floto RA
J Cyst Fibros; 2015 May; 14(3):293-304. PubMed ID: 25881770
[TBL] [Abstract][Full Text] [Related]
7. Challenging and emerging pathogens in cystic fibrosis.
de Vrankrijker AM; Wolfs TF; van der Ent CK
Paediatr Respir Rev; 2010 Dec; 11(4):246-54. PubMed ID: 21109184
[TBL] [Abstract][Full Text] [Related]
8. Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline.
Bacci G; Paganin P; Lopez L; Vanni C; Dalmastri C; Cantale C; Daddiego L; Perrotta G; Dolce D; Morelli P; Tuccio V; De Alessandri A; Fiscarelli EV; Taccetti G; Lucidi V; Bevivino A; Mengoni A
PLoS One; 2016; 11(6):e0156807. PubMed ID: 27355625
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections.
Heirali A; McKeon S; Purighalla S; Storey DG; Rossi L; Costilhes G; Drews SJ; Rabin HR; Surette MG; Parkins MD
PLoS One; 2016; 11(2):e0148534. PubMed ID: 26859493
[TBL] [Abstract][Full Text] [Related]
10. Development of the Nasopharyngeal Microbiota in Infants with Cystic Fibrosis.
Prevaes SM; de Winter-de Groot KM; Janssens HM; de Steenhuijsen Piters WA; Tramper-Stranders GA; Wyllie AL; Hasrat R; Tiddens HA; van Westreenen M; van der Ent CK; Sanders EA; Bogaert D
Am J Respir Crit Care Med; 2016 Mar; 193(5):504-15. PubMed ID: 26492486
[TBL] [Abstract][Full Text] [Related]
11.
Menetrey Q; Sorlin P; Jumas-Bilak E; Chiron R; Dupont C; Marchandin H
Genes (Basel); 2021 Apr; 12(5):. PubMed ID: 33919046
[TBL] [Abstract][Full Text] [Related]
12. Lung microbiota across age and disease stage in cystic fibrosis.
Coburn B; Wang PW; Diaz Caballero J; Clark ST; Brahma V; Donaldson S; Zhang Y; Surendra A; Gong Y; Elizabeth Tullis D; Yau YC; Waters VJ; Hwang DM; Guttman DS
Sci Rep; 2015 May; 5():10241. PubMed ID: 25974282
[TBL] [Abstract][Full Text] [Related]
13. The airway microbiome in cystic fibrosis and implications for treatment.
Zemanick ET; Sagel SD; Harris JK
Curr Opin Pediatr; 2011 Jun; 23(3):319-24. PubMed ID: 21494150
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of changes in Pseudomonas aeruginosa load during treatment of a pulmonary exacerbation in cystic fibrosis.
Reid DW; Latham R; Lamont IL; Camara M; Roddam LF
J Cyst Fibros; 2013 Dec; 12(6):688-99. PubMed ID: 23706827
[TBL] [Abstract][Full Text] [Related]
15. Emerging and unusual gram-negative infections in cystic fibrosis.
Davies JC; Rubin BK
Semin Respir Crit Care Med; 2007 Jun; 28(3):312-21. PubMed ID: 17562501
[TBL] [Abstract][Full Text] [Related]
16. Induced sputum compared to bronchoalveolar lavage in young, non-expectorating cystic fibrosis children.
Blau H; Linnane B; Carzino R; Tannenbaum EL; Skoric B; Robinson PJ; Robertson C; Ranganathan SC
J Cyst Fibros; 2014 Jan; 13(1):106-10. PubMed ID: 23806622
[TBL] [Abstract][Full Text] [Related]
17. Which pathogens should we worry about?
Jones AM
Paediatr Respir Rev; 2019 Aug; 31():15-17. PubMed ID: 30967346
[TBL] [Abstract][Full Text] [Related]
18. RISA-HPLC analysis of lung bacterial colonizers of cystic fibrosis children.
Nazaret S; Assade F; Brothier E; Freydière AM; Bellon G; Cournoyer B
J Microbiol Methods; 2009 Jan; 76(1):58-69. PubMed ID: 18929602
[TBL] [Abstract][Full Text] [Related]
19. [Emerging bacteria in cystic fibrosis and non-cystic fibrosis bronchiectasis from a microbiologist's perspective].
Menetrey Q; Dupont C; Chiron R; Marchandin H
Rev Mal Respir; 2020 Sep; 37(7):561-571. PubMed ID: 32684338
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology and management of pulmonary infections in cystic fibrosis.
Gibson RL; Burns JL; Ramsey BW
Am J Respir Crit Care Med; 2003 Oct; 168(8):918-51. PubMed ID: 14555458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
